Raymond James Downgrades Nivalis Therapeutics (NVLS) to Market Perform

November 29, 2016 7:39 AM EST
Get Alerts NVLS Hot Sheet
Price: $2.17 -8.44%

Rating Summary:
    1 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 31 | New: 25
Trade NVLS Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Raymond James downgraded Nivalis Therapeutics (NASDAQ: NVLS) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Nivalis Therapeutics click here. For more ratings news on Nivalis Therapeutics click here.

Shares of Nivalis Therapeutics closed at $6.25 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Raymond James

Add Your Comment